High Hopes from Novel Melanoma Prevention Vaccine
The International Agency for Research on Cancer (IARC) is kicking off Melanoma Awareness Month by emphasising the burden of...
Recent developments in chemotherapy targeting could benefit patients
Because most chemotherapy drugs are quite toxic, doctors and patients need to carefully balance the risks and benefits of...
Addition of a spider silk protein to p53 shuts down cancer cells
Our cells are protected from cancer by the p53 protein, which is a promising target for cancer therapy. The...
Camptothecin: An anti-cancer drug that induces weight loss
According to a new study published in the open-access journal PLOS Biology, an anti-tumor drug promotes weight loss in...
Chronic Lymphocytic Leukemia – the shift from FISH to Next Gen sequencing
DNA – You hear it everywhere, but why are scientists so interested in its wonders? Well, DNA is like...
NTRK fusion tumors in adult and pediatric patients
Neurotrophic Tyrosine Kinase genes (NTRK1, NTRK2 and NTRK3) encode members of the tyrosine receptor kinase (TRK) protein family: TRKA,...
Alcohol: A direct carcinogen impairing DNA repair
Alcohol causes cancer directly, according to new evidence from a large-scale genetic study led by Oxford Population Health. A...
Advancements in clinical trials can pave the way to innovative treatment
Clinical trials and research aim to study new tests and treatments and evaluate the outcome of a study on...
Cervical Cancer: It’s Not Only Preventable But Treatable
Overview Cervical cancer is developed when the cells of the cervix (entrance to the uterus from the vagina) grow...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 3: HER2
Human epidermal growth factor receptor 2 (HER2) is a member of the ERBB receptor tyrosine kinase family. It is...